To capture the natural history of COVID-19 associated olfactory dysfunction as measured by two patient reported outcome measures (SNOT-22, QOD-NS) and a 6-week BSIT with a comparison to an intervention arm receiving daily omega-3 supplements.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Brief Smell Identification Test (BSIT)
Timeframe: Week 0 and Week 6
Change in Brief Smell Identification Test (BSIT) in Participants With Severe Olfactory Dysfunction
Timeframe: Week 0 and Week 6
Change in Brief Smell Identification Test (BSIT) in Participants With Laboratory-Confirmed COVID-19 and Severe Olfactory Dysfunction
Timeframe: Week 0 and Week 6
Change in Brief Smell Identification Test (BSIT) in Participants With Laboratory-Confirmed COVID-19
Timeframe: Week 0 and Week 6